Mexidol with robotic rehabilitation in 47 children with spastic cerebral palsy
Comparison in people · 2026
- What was studied
- 47 children aged 6–8 years with spastic cerebral palsy. Mexidol plus robotic rehabilitation: 24. Robotic rehabilitation alone: 23.
- Main finding
- The authors reported improvements of 37.6–58.7% across motor measures with Mexidol plus robotic rehabilitation, versus 24–39% with rehabilitation alone.
Reported findings and study design
Add-on comparison using robotic biofeedback and exoskeleton measurements, with serum cytokine and oxidative-stress assays.
Population or model 47 children aged 6–8 years with spastic cerebral palsy. Mexidol plus robotic rehabilitation: 24. Robotic rehabilitation alone: 23.
Dose, route and schedule
Six weeks of robotic rehabilitation with biofeedback. The abstract does not give the Mexidol dose, route, or session frequency.
Protocol source ↗ · Original publisher abstract, arm sizes, rehabilitation methods and functional result ranges.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Improvement across motor measures | 37.6–58.7% vs 24–39% | Week 6 · p<0.05 for the reported between-group comparison |
| Improvement across cognitive measures | 14.4–52.6% vs 5–22% | Week 6 · p<0.05 for the reported between-group comparison |
Source for these results ↗ · Reviewed 2026-11-15
Study limitations and source details
Study limitations
- The abstract gives ranges across different tests. It omits individual scale values, allocation and masking details, and the drug regimen.
Source details
Original publisher abstract, arm sizes, rehabilitation methods and functional result ranges.
Sources checked
Citation
Published
D. D. Gaynetdinova, L. Z. Afandieva. Mexidol with robotic rehabilitation in 47 children with spastic cerebral palsy Korsakov Journal of Neurology and Psychiatry. 2026;126(5):74–82.
Study source ↗ · DOI 10.17116/jnevro202612605174 · Bibliography entry · Link to this summary